Jasper Therapeutics is a biotechnology company focused on enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies.
Jasper’s lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant.
Location: United States, California, Redwood City
Employees: 11-50
Total raised: $85M
Investors 2
| Date | Name | Website |
| - | Avego | avego.com |
| - | Abingworth... | abingworth... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 09.01.2020 | Series A | $50M | - |
| 09.12.2019 | Series A | $35M | Abingworth... |
Mentions in press and media 5
| Date | Title | Description | Source |
| 06.02.2024 | Jasper Therapeutics Announces Pricing of $50 Million Underwr... | - | globenewsw... |
| 09.01.2020 | Jasper Therapeutics Announces Expansion of Series A Financin... | - | abingworth... |
| 09.01.2020 | Jasper Therapeutics Raises Additional $14.1M in Series A Fin... | Jasper Therapeutics, Inc., a Palo Alto, Calif.-based biotechnology company focused on hematopoietic ... | finsmes.co... |
| 09.12.2019 | Jasper Therapeutics Launches with $35M Series A | PALO ALTO, CA, Jasper Therapeutics announced the launch of the company with a $35 million total Se... | vcnewsdail... |
| 07.12.2019 | Jasper Therapeutics Raises $35M in Series A Financing | Jasper Therapeutics, Inc., a Palo Alto, Calif.-based new biotechnology company, raised $35m in Serie... | finsmes.co... |